Sign up to save your podcasts
Or
Share Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Episode 53. Belantamab Makes a Comeback with Dr. Hang Quach
In this episode, we discuss the comeback of belantamab mafadotin in multiple myeloma with Dr. Hang Quach, along with some other important abstracts presented at EHA/ASCO 2024. Here are the studies we discussed:
1. DREAMM-7 RCT: Belantamab-Vd vs Daratumumab-Vd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828933/
2. DREAMM-8 RCT: Belantamab-Pd vs PVd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828951/
3. Long-term follow-up of CASSIOPEIA Trial: https://pubmed.ncbi.nlm.nih.gov/38889735/
4. Update on MRD data from PERSEUS Trial: https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.7502
View all episodes
By Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff
4.8
4848 ratings
In this episode, we discuss the comeback of belantamab mafadotin in multiple myeloma with Dr. Hang Quach, along with some other important abstracts presented at EHA/ASCO 2024. Here are the studies we discussed:
1. DREAMM-7 RCT: Belantamab-Vd vs Daratumumab-Vd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828933/
2. DREAMM-8 RCT: Belantamab-Pd vs PVd in relapsed MM. https://pubmed.ncbi.nlm.nih.gov/38828951/
3. Long-term follow-up of CASSIOPEIA Trial: https://pubmed.ncbi.nlm.nih.gov/38889735/
4. Update on MRD data from PERSEUS Trial: https://ascopubs.org/doi/10.1200/JCO.2024.42.16_suppl.7502
More shows like Blood Cancer Talks
View all
Hematologic Oncology Update
72 Listeners
NEJM This Week
325 Listeners
Research To Practice | Oncology Videos
113 Listeners
The Hematologist
26 Listeners
JAMA Clinical Reviews
496 Listeners
VJHemOnc Podcast
3 Listeners
Annals On Call Podcast
194 Listeners
Plenary Session - inactive due to federal service
755 Listeners
Treating Blood Cancers
12 Listeners
Blood Podcast
51 Listeners
The BSH Guidelines Official Podcast
2 Listeners
EHA Unplugged
1 Listeners
WolverHeme Happy Hour
29 Listeners
Two Onc Docs
169 Listeners
Oncology Brothers: Practice-Changing Cancer Discussions
39 Listeners